{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:26:29Z","timestamp":1793924789418,"version":"4.8.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13167-9","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T03:10:14Z","timestamp":1732245014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives"],"prefix":"10.1186","volume":"24","author":[{"given":"Lucas Frederik","family":"van Schaik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Gurumay","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim Herbert","family":"van Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valesca Pavlawna","family":"Ret\u00e8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"1","key":"13167_CR1","doi-asserted-by":"publisher","first-page":"a000570","DOI":"10.1101\/mcs.a000570","volume":"1","author":"J Laskin","year":"2015","unstructured":"Laskin J, Jones S, Aparicio S, Chia S, Ch\u2019ng C, Deyell R, et al. Lessons learned from the application of whole-genome analysis to the treatment of patients with Advanced Cancers. Cold Spring Harb Mol Case Stud. 2015;1(1):a000570.","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"2","key":"13167_CR2","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/S1470-2045(15)00620-8","volume":"17","author":"V Prasad","year":"2016","unstructured":"Prasad V, Fojo T, Brada M. Precision Oncology: origins, Optimism, and potential. Lancet Oncol. 2016;17(2):e81\u20136.","journal-title":"Lancet Oncol"},{"key":"13167_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG. Immune Checkpoint inhibitors for the treatment of Cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol. 2021;16:223\u201349.","journal-title":"Annu Rev Pathol"},{"issue":"10229","key":"13167_CR4","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","volume":"395","author":"PL Bedard","year":"2020","unstructured":"Bedard PL, Hyman DM, Davids MS, Siu LL. Small molecules, big impact: 20 years of targeted therapy in Oncology. Lancet. 2020;395(10229):1078\u201388.","journal-title":"Lancet"},{"issue":"1","key":"13167_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12916-021-02070-w","volume":"19","author":"S Ramagopalan","year":"2021","unstructured":"Ramagopalan S, Leahy TP, Ray J, Wilkinson S, Sammon C, Subbiah V. The value of Innovation: Association between Improvements in Survival of Advanced and Metastatic Non-small Cell Lung Cancer and targeted and Immunotherapy. BMC Med. 2021;19(1):209.","journal-title":"BMC Med"},{"issue":"8","key":"13167_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, et al. Efficacy of Larotrectinib in trk Fusion-positive cancers in adults and children. N Engl J Med. 2018;378(8):731\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"13167_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jmoldx.2021.01.004","volume":"23","author":"M van de Ven","year":"2021","unstructured":"van de Ven M, Koffijberg H, Ret\u00e8l V, Monkhorst K, Smit E, van Harten W, et al. Real-world utilization of Biomarker Testing for patients with Advanced Non-small Cell Lung Cancer in a Tertiary Referral Center and referring hospitals. J Mol Diagn. 2021;23(4):484\u201394.","journal-title":"J Mol Diagn"},{"issue":"3","key":"13167_CR8","doi-asserted-by":"publisher","first-page":"e0264138","DOI":"10.1371\/journal.pone.0264138","volume":"17","author":"CA Milbury","year":"2022","unstructured":"Milbury CA, Creeden J, Yip WK, Smith DL, Pattani V, Maxwell K, et al. Clinical and Analytical Validation of Foundationone\u00aeCdx, a comprehensive genomic profiling assay for solid tumors. PLoS ONE. 2022;17(3):e0264138.","journal-title":"PLoS ONE"},{"key":"13167_CR9","doi-asserted-by":"publisher","first-page":"e2200245","DOI":"10.1200\/PO.22.00245","volume":"6","author":"E Cuppen","year":"2022","unstructured":"Cuppen E, Elemento O, Rosenquist R, Nikic S, Zaleski MIJ. Implementation of whole-genome and transcriptome sequencing into Clinical Cancer Care. JCO Precis Oncol. 2022;6:e2200245.","journal-title":"JCO Precis Oncol"},{"key":"13167_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00311","volume":"2","author":"D Weymann","year":"2018","unstructured":"Weymann D, Pataky R, Regier DA. Economic evaluations of Next-Generation Precision Oncology: a critical review. JCO Precis Oncol. 2018;2:1\u201323.","journal-title":"JCO Precis Oncol"},{"key":"13167_CR11","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1017\/gmh.2015.29","volume":"3","author":"A Perez-Gomez","year":"2016","unstructured":"Perez-Gomez A, Mejia-Trujillo J, Mejia A. How useful are randomized controlled trials in a rapidly changing World? Glob Ment Health (Camb). 2016;3:e6.","journal-title":"Glob Ment Health (Camb)"},{"issue":"5","key":"13167_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jval.2019.11.010","volume":"23","author":"E Faulkner","year":"2020","unstructured":"Faulkner E, Holtorf AP, Walton S, Liu CY, Lin H, Biltaj E, et al. Being Precise about Precision Medicine: what should Value Frameworks incorporate to address Precision Medicine? A report of the Personalized Precision Medicine Special Interest Group. Value Health. 2020;23(5):529\u201339.","journal-title":"Value Health"},{"issue":"12","key":"13167_CR13","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s40273-018-0686-6","volume":"36","author":"J Love-Koh","year":"2018","unstructured":"Love-Koh J, Peel A, Rejon-Parrilla JC, Ennis K, Lovett R, Manca A, et al. The future of Precision Medicine: potential impacts for Health Technology Assessment. PharmacoEconomics. 2018;36(12):1439\u201351.","journal-title":"PharmacoEconomics"},{"issue":"1","key":"13167_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1186\/s12885-019-5920-x","volume":"19","author":"MC Best","year":"2019","unstructured":"Best MC, Bartley N, Jacobs C, Juraskova I, Goldstein D, Newson AJ, et al. Patient perspectives on Molecular Tumor profiling: why wouldn\u2019t you? BMC Cancer. 2019;19(1):753.","journal-title":"BMC Cancer"},{"key":"13167_CR15","doi-asserted-by":"crossref","unstructured":"van Schaik LF, Engelhardt EG, Wilthagen EA, Steeghs N, Coves AF, Joore MA et al. Factors for a Broad Technology Assessment of Comprehensive genomic profiling in Advanced Cancer, a systematic review. Crit Rev Oncol Hematol. 2024:104441.","DOI":"10.1016\/j.critrevonc.2024.104441"},{"issue":"12","key":"13167_CR16","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1111\/jan.13031","volume":"72","author":"H Kallio","year":"2016","unstructured":"Kallio H, Pietil\u00e4 AM, Johnson M, Kangasniemi M. Systematic methodological review: developing a Framework for a qualitative semi-structured interview guide. J Adv Nurs. 2016;72(12):2954\u201365.","journal-title":"J Adv Nurs"},{"issue":"2","key":"13167_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jval.2015.12.016","volume":"19","author":"K Marsh","year":"2016","unstructured":"Marsh K, M IJ, Thokala P, Baltussen R, Boysen M, Kal\u00f3 Z, et al. Multiple Criteria Decision Analysis for Health Care decision making\u2013Emerging Good practices: Report 2 of the Ispor Mcda Emerging Good practices Task Force. Value Health. 2016;19(2):125\u201337.","journal-title":"Value Health"},{"issue":"2","key":"13167_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"1","key":"13167_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-022-03432-5","volume":"20","author":"\u00c5 Helland","year":"2022","unstructured":"Helland \u00c5, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, et al. Improving Public Cancer Care by implementing Precision Medicine in Norway: impress-Norway. J Transl Med. 2022;20(1):225.","journal-title":"J Transl Med"},{"issue":"7","key":"13167_CR20","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1158\/1078-0432.CCR-21-3752","volume":"28","author":"LR Hoes","year":"2022","unstructured":"Hoes LR, van Berge Henegouwen JM, van der Wijngaart H, Zeverijn LJ, van der Velden DL, van de Haar J, et al. Patients with rare cancers in the Drug Rediscovery Protocol (Drup) Benefit from Genomics-guided treatment. Clin Cancer Res. 2022;28(7):1402\u201311.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"13167_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12885-023-10632-9","volume":"23","author":"T Kringelbach","year":"2023","unstructured":"Kringelbach T, H\u00f8jgaard M, Rohrberg K, Spanggaard I, Laursen BE, Ladekarl M, et al. Protarget: a Danish nationwide clinical trial on targeted Cancer Treatment based on genomic profiling - a National, phase 2, Prospective, Multi-Drug, non-randomized, open-label Basket Trial. BMC Cancer. 2023;23(1):182.","journal-title":"BMC Cancer"},{"key":"13167_CR22","unstructured":"Clinicaltrials.gov. A Molecularly Guided Anti-Cancer Drug Off-Label Trial (Megalit) [ https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04185831. Accessed on 13\u2009\u2013\u200910 2023]."},{"issue":"11","key":"13167_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1001\/jamaoncol.2016.2129","volume":"2","author":"M Schwaederle","year":"2016","unstructured":"Schwaederle M, Zhao M, Lee JJ, Lazar V, Leyland-Jones B, Schilsky RL, et al. Association of Biomarker-Based Treatment Strategies with response rates and progression-free survival in Refractory Malignant neoplasms: a Meta-analysis. JAMA Oncol. 2016;2(11):1452\u20139.","journal-title":"JAMA Oncol"},{"key":"13167_CR24","unstructured":"Zorginstituut. Stand Van Wetenschap En Praktijk 2023 https:\/\/www.zorginstituutnederland.nl\/publicaties\/publicatie\/2023\/04\/11\/beoordeling-swp-20232023 [Accessed on 05\u201311 2023]."},{"issue":"5","key":"13167_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12687-020-00503-2","volume":"13","author":"C Lejeune","year":"2022","unstructured":"Lejeune C, Amado IF. Valuing genetic and genomic testing in France: current challenges and latest evidence. J Community Genet. 2022;13(5):477\u201385.","journal-title":"J Community Genet"},{"key":"13167_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.semcancer.2021.05.026","volume":"84","author":"A Stenzinger","year":"2022","unstructured":"Stenzinger A, Edsj\u00f6 A, Ploeger C, Friedman M, Fr\u00f6hling S, Wirta V, et al. Trailblazing Precision Medicine in Europe: a joint view by genomic Medicine Sweden and the centers for Personalized Medicine, Zpm, in Germany. Semin Cancer Biol. 2022;84:242\u201354.","journal-title":"Semin Cancer Biol"},{"issue":"16suppl","key":"13167_CR27","doi-asserted-by":"publisher","first-page":"e13634","DOI":"10.1200\/JCO.2022.40.16_suppl.e13634","volume":"40","author":"K Tasken","year":"2022","unstructured":"Tasken K, Russnes H, Helland A, Aas E, Bj\u00f8rge L, Blix ES, et al. Prototype Precision Oncology Learning Ecosystem: Norwegian Precision Cancer Medicine implementation Initiative. J Clin Oncol. 2022;40(16suppl):e13634\u2013e.","journal-title":"J Clin Oncol"},{"key":"13167_CR28","unstructured":"NHS. A Strategy for Embedding Genomics in the Nhs over the Next 5 Years. 2022 [ https:\/\/www.england.nhs.uk\/long-read\/accelerating-genomic-medicine-in-the-nhs\/#3-enabling-genomics-to-be-at-the-forefront-of-the-data-and-digital-revolution. Accessed on 02-11-2023 2023]."},{"issue":"1","key":"13167_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12874-022-01571-3","volume":"22","author":"M van de Ven","year":"2022","unstructured":"van de Ven M, M IJ, Ret\u00e8l V, van Harten W, Koffijberg H. Developing a dynamic Simulation Model to support the nationwide implementation of whole genome sequencing in Lung Cancer. BMC Med Res Methodol. 2022;22(1):83.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"13167_CR30","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.2196\/jmir.8775","volume":"19","author":"T Greenhalgh","year":"2017","unstructured":"Greenhalgh T, Wherton J, Papoutsi C, Lynch J, Hughes G, A\u2019Court C, et al. Beyond adoption: a New Framework for Theorizing and evaluating nonadoption, abandonment, and challenges to the Scale-up, spread, and sustainability of Health and Care technologies. J Med Internet Res. 2017;19(11):e367.","journal-title":"J Med Internet Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13167-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T03:21:06Z","timestamp":1732245666000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13167-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13167"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13167-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of the Antoni van Leeuwenhoek hospital (IRBd23-111). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1441"}}